Skip to main content
SpringerLink
Log in

Bone

Primary malignant lymphoma and multiple myeloma are not included

  • Chapter
AJCC Cancer Staging Manual

Summary of Changes

T1 has changed from “Tumor confined within the cortex” to “Tumor 8 cm or less in greatest dimension.”

T2 has changed from “Tumor invades beyond the cortex” to “Tumor more than 8 cm in greatest dimension.”

T3 designation of skip metastasis is defined as “Discontinuous tumors in the primary bone site.” This designation is a Stage III tumor that was not previously defined.

M1 lesions have been divided into M1a and M1b.

M1a is lung-only metastases.

M1b is metastases to other distant sites, including lymph nodes.

In the Stage Grouping, Stage IVA is M1a, and Stage IVB is Mlb

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Bacci G, Ferrari S, Bertoni F, et al: Prognostic factors in non-metastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 18:4–11, 2000

    PubMed  CAS  Google Scholar 

  • Baldini M, Scotlani K, Barbanti-Brodano G, et al: Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 333:1380–1385, 1995

    Article  PubMed  CAS  Google Scholar 

  • Bieling P, Rehan N, Winkler P, et al: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 14(3): 848–858, 1996

    PubMed  CAS  Google Scholar 

  • Cotterill SJ, Ahrens S, Paulussen M, et al: Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 18:3108–3114, 2000

    PubMed  CAS  Google Scholar 

  • Davis A, Bell R, Goodwin P: Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12(2):423–431, 1994

    PubMed  CAS  Google Scholar 

  • de Alva E, Antonescu CR, Panizo A, et al: Prognostic impact of P53 status in Ewing sarcoma. Cancer; 89:783–792, 2000

    Article  Google Scholar 

  • de Alva E, Kawai A, Healey JH, et al: EWS-FL11 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J Clin Oncol 16:1248–1255, 1998

    Google Scholar 

  • Enneking WF, Spanier S, Goodman M: A system for the surgical staging of musculoskeletal sarcoma. Clin Orth and Rel Research No. 153, 106–120, 1980

    Google Scholar 

  • Evans R, Nesbit M, Askin F, et al: Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with nonmetastatic Ewing’s sarcoma of the pelvic bones. Int J Radiat Oncol Biol Phys 11:129–136, 1985

    Article  PubMed  CAS  Google Scholar 

  • Glasser DB, Lane JM, Huvos AG, et al: Survival, prognosis and therapeutic response in osteosarcoma: the Memorial Hospital experience. Cancer 67:698–708, 1992

    Article  Google Scholar 

  • Gorlick R, Hubos AG, Heller G, et al: Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol 17:2781–2788, 1999

    PubMed  CAS  Google Scholar 

  • Hornicek FJ, Gebhardt MC, Wolfe M, et al: P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Clin Orthop and Rel Research 373:11–17, 2000

    Article  Google Scholar 

  • Mankin HJ, Mankin CJ, Simon MA: The hazards of biopsy, revisited. J Bone and Joint Surg 78A:659–663, 1996

    Google Scholar 

  • Peabody TD, Gibbs CP, Simon MA: Evaluation and staging of musculoskeletal neoplasms. J Bone and Joint Surg 80A: 1204–1218, 1998

    CAS  Google Scholar 

  • Scully SP, Temple HT, Okeefe RJ, et al: Role of surgical resection in pelvic Ewing’s sarcoma. J Clin Oncol 13(9):2336–2341, 1995

    PubMed  CAS  Google Scholar 

  • Simon MA, Bierman JS: Biopsy of bone and soft-tissue lesions. J Bone and Joint Surg 75A:616–621, 1993

    CAS  Google Scholar 

  • Sundaram M, McDonald DJ: Magnetic resonance imaging in the evaluation of the solitary tumor of bone. Current Opinion in Radiology 2:697–702, 1990

    PubMed  CAS  Google Scholar 

  • Sundaram M, McDonald DJ: The solitary tumor or tumor-like lesion of bone. Top Magn Reson Imag 1(4): 17–29, 1989

    Article  CAS  Google Scholar 

  • Sundaram M, McGuire MH: Computed tomography or magnetic resonance for evaluating the solitary tumor or tumorlike lesion of bone? Skeletal Radiology 17:393–401, 1988

    Article  PubMed  CAS  Google Scholar 

  • Ward WG, Mikaelian K, Dorey F, et al: Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 12(9):1849–1858, 1994

    PubMed  CAS  Google Scholar 

  • Wei G, Antonescu CR, de Alva E, et al: Prognostic impact of INK4A deletion in Ewing sarcoma. Cancer 89:793–799, 2000

    Article  PubMed  CAS  Google Scholar 

  • Wuisman P, Enneking WF: Prognosis for patients who have osteosarcoma with skip metastasis. J Bone and Joint Surg 72A(l):60–68, 1990

    CAS  Google Scholar 

  • Wunder JS, Bull SB, Aneliunas V, et al: MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 18:2685–2694, 2000

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    American Joint Committee on Cancer

    Editor information

    Editors and Affiliations

    1. Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina, USA

      Frederick L. Greene M.D. (Chair) (Chair)

    2. Vanderbilt University Medical Center, Nashville, Tennessee, USA

      David L. Page M.D. (Professor of Pathology and Epidemiology) (Professor of Pathology and Epidemiology)

    3. Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA

      Irvin D. Fleming M.D. (Professor) (Professor)

    4. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA

      April G. Fritz C.T.R., R.H.I.T.

    5. The Johns Hopkins School of Medicine, Baltimore, Maryland, USA

      Charles M. Balch M.D. (Professor of Surgery and Oncology) (Professor of Surgery and Oncology)

    6. University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA

      Daniel G. Haller M.D. (Professor of Medicine, Associate Chief for Clinical Affairs) (Professor of Medicine, Associate Chief for Clinical Affairs)

    7. Lynn Sage Breast Center, School of Medicine, Northwestern University, Chicago, Illinois, USA

      Monica Morrow M.D. (Professor of Surgery and Director) (Professor of Surgery and Director)

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2002 Springer Science+Business Media New York

    About this chapter

    Cite this chapter

    American Joint Committee on Cancer. (2002). Bone. In: Greene, F.L., et al. AJCC Cancer Staging Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3656-4_21

    Download citation

    • DOI: https://doi.org/10.1007/978-1-4757-3656-4_21

    • Publisher Name: Springer, New York, NY

    • Print ISBN: 978-3-540-00595-7

    • Online ISBN: 978-1-4757-3656-4

    • eBook Packages: Springer Book Archive

    Publish with us

    Policies and ethics

    Search

    Navigation